Disease
Psoriasis
Chronic, immune-mediated inflammatory skin disease driven by IL-23/Th17-axis dysregulation, presenting as well-demarcated erythematous plaques with silvery scale; the most common presentation is chronic plaque psoriasis, though pustular and erythrodermic subtypes also occur.
Coverage in progress. AssetMemo has not yet run its full census for Plaque Psoriasis, so the assets listed for it are not complete.
Combined attributable cost
$87.4B+
Drug spend
Not yet sourced
Sum of 2 indications below.